Libya vs Republic of Moldova: Access to anti-retroviral drugs, male
Libya
49.0%
in 2023
Republic of Moldova
47.0%
in 2024
Libya rank
119th
Republic of Moldova rank
122nd
Access to anti-retroviral drugs, male over time
- Libya
- Republic of Moldova
How they compare
Libya currently reports 49.0% against 47.0% in Republic of Moldova, a difference of 2.0%.
Across all 24 years both countries report, Libya has been ahead every year.
Libya ranks 119th and Republic of Moldova ranks 122nd of 141 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.0% | 1.4% | 27.6% | Libya |
| 2010s | 63.9% | 16.0% | 47.9% | Libya |
| 2020s | 47.8% | 37.2% | 10.5% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Libya or Republic of Moldova?
- Libya, at 49.0% against 47.0% in Republic of Moldova as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Libya and Republic of Moldova?
- 2.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Republic of Moldova?
- 24 years are reported by both, from 2000 to 2023.
- How do Libya and Republic of Moldova rank globally for access to anti-retroviral drugs, male?
- Libya ranks 119th and Republic of Moldova ranks 122nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.